AventaCell

AventaCell Biomedical is a life sciences company specializing in the development and commercialization of human-derived solutions for cell culture and tissue regeneration. The company is a leader in the production of human platelet lysates (HPL), which serve as high-performance, animal-free alternatives to Fetal Bovine Serum (FBS) for the expansion of stem cells and other primary cells. Their flagship UltraGRO product line is designed to support the transition of cell-based therapies from research to clinical-scale manufacturing by providing GMP-compliant, xeno-free growth supplements. AventaCell's technology addresses critical safety and efficiency needs in the regenerative medicine and immunotherapy sectors. As a subsidiary of Macopharma, the company leverages global expertise in blood component processing to provide standardized, high-quality supplements to researchers and clinicians worldwide.